Prostate Cancer

Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy. July 30, 2021

A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study. July 30, 2021

Robotic-assisted radical prostatectomy with the Senhance® robotic platform: single center experience. July 30, 2021

Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer. July 30, 2021

Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials. July 29, 2021

Cardiovascular toxicities associated with abiraterone compared to enzalutamide-A pharmacovigilance study. July 29, 2021

Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients. July 29, 2021

Intermediate-risk Prostate Cancer-A Sheep in Wolf's Clothing? July 29, 2021

RNA splicing factors SRRM3 and SRRM4 distinguish molecular phenotypes of castration-resistant neuroendocrine prostate cancer. July 29, 2021

New Data Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer July 28, 2021

Nurse-led telephone notification of a prostate cancer diagnosis: Prospective analysis of men's preferences for and experiences of a same-day assessment and diagnostic clinic. July 28, 2021

The modified ISUP system improves concordance between biopsy and prostatectomy tumour grade. July 28, 2021

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease. July 28, 2021

Efficacy, Use, and Acceptability of a Web-Based Self-management Intervention Designed to Maximize Sexual Well-being in Men Living With Prostate Cancer: Single-Arm Experimental Study. July 28, 2021

Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis. July 28, 2021

Diagnostic accuracy of the Novel 29 MHz micro-ultrasound "ExactVuTM" for the detection of clinically significant prostate cancer: A prospective single institutional study. A step forward in the diagnosis of prostate cancer. July 27, 2021

Prognostic implication of staging of seminal vesicle invasion in patients with prostatic adenocarcinoma after prostatectomy. July 27, 2021

Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection. July 27, 2021

Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study. July 27, 2021

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA. July 27, 2021

Page 1 of 1164